59
Participants
Start Date
November 26, 2015
Primary Completion Date
April 8, 2025
Study Completion Date
April 8, 2025
Adalimumab
every other week or weekly subcutaneous injection
Arnold Palmer Hospital /ID# 147295, Orlando
MultiCare Institute Health System /ID# 169005, Tacoma
MNGI Digestive Health, P. A. /ID# 147294, Minneapolis
Mayo Clinic - Rochester /ID# 147304, Rochester
Kurume University Hospital /ID# 145710, Kurume-shi
Juntendo University Hospital /ID# 147315, Bunkyo-ku
National Center for Child Health and Development /ID# 147312, Setagaya-ku
Uniwersytecki Szpital Dzieciecy w Krakowie /ID# 147279, Krakow
Uniwersytecki Szpital Kliniczny im. Jana Mikulicza-Radeckiego /ID# 147310, Wroclaw
Centrum Zdrowia MDM /ID# 147280, Warsaw
Gabinet Lekarski Bartosz Korcz /ID# 147281, Rzeszów
Instytut Centrum Zdrowia Matki Polki /ID# 169017, Lodz
Univerzitna nemocnica Martin /ID# 147283, Martin
Hospital Universitario Vall d'Hebron /ID# 147288, Barcelona
Disc_Barts Health NHS Trust - The Royal London Hospital /ID# 147290, London
Duplicate_The Royal Free London NHS Foundation Trust /ID# 147292, London
Lead Sponsor
AbbVie
INDUSTRY